| [1] |
Bachor R,Kotzerke J,Gottfried HW,et al,Positron emission tomography in diagnosis of renal cell carcinoma.Urology,1996,35(2):146-150.
|
| [2] |
Miyauchi T,Brown RS,Grossman HB,et al.Correlation between visualization of primary renal cancer by FDG-PET and histopathological findings.J Nucl Med,1996,37(1):64.
|
| [3] |
Ramdave S,Thomas GW,Berlangieri SU,et al.Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.J Urol,2001,166(3):825-830.
|
| [4] |
Kang DE,White RL Jr,Zuger JH,et al.Clinical use of fluorodeoxyglucose F-18 positron emission tomography for detection of renal cell carcinoma.J Urol,2004,171(5):1806-1809.
|
| [5] |
Aide N,Cappele O,Bottet P,et al.Efficiency of[(18)F]FDG PET in characterising renal cancer and detecting distant metastases:a comparison with CT.Eur J Nucl Med Mol Imaging,2003,30(9):1236-1245.
|
| [6] |
Hain SF,Gleadle J,Maisey MN,etal.F-18fluorodeoxyglucose PET in the diagnosis of vascular invasion in renal cell carcinoma.Clin Nucl Med,1999,24(10):819-820.
|
| [7] |
Seto E,Segall GM,Terris MK.Positron emission tomography detection of osseous metastases of renal cell carcinoma not identified on bone scan.Urology,2000,55(2):286.
|
| [8] |
Poggi MM,Patronas N,Buttman JA,et al.Intramedullary spinal cord metastases fuom renal cell carcinoma:detection by positron emission tomography.Clin Nucl Med,2001,26(10):837-839.
|